Renal graft irradiation in acute rejection.
To evaluate the effect of graft irradiation in the treatment of acute rejection of renal transplants, a randomized study was conducted from 1978 to 1981. Patients with acute rejection were given standard medical management in the form of intravenous methylprednisolone, and were chosen randomly to receive either graft irradiation (175 rads every other day, to a total of 525 rads) or simulated (sham) irradiation. Eighty-three rejections occurring in 64 grafts were randomized to the protocol. Rejection reversal was recorded in 84.5% of control grafts and 75% of the irradiated grafts. Recurrent rejections were more frequent and graft survival was significantly lower in the irradiated group (22%) than in the control group (54%). Graft irradiation does not appear to be beneficial in the treatment of acute rejection of renal transplants when used in conjunction with high-dose steroids.
D005260:Female; D006084:Graft Rejection / Q000187:drug effects / Q000528:radiation effects*; D006085:Graft Survival / Q000528:radiation effects; D006801:Humans; D007668:Kidney / Q000528:radiation effects; D016030:Kidney Transplantation; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D011446:Prospective Studies; D011897:Random Allocation; D012008:Recurrence
D008775:Methylprednisolone